Comparing risk-adjustment methods for provider profiling
โ Scribed by Elizabeth R. DeLong; Eric D. Peterson; David M. DeLong; Lawrence H. Muhlbaier; Suzanne Hackett; Daniel B. Mark
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 282 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0277-6715
No coin nor oath required. For personal study only.
โฆ Synopsis
Risk-adjustment and provider profiling have become common terms as the medical profession attempts to measure quality and assess value in health care. One of the areas of care most thoroughly developed in this regard is quality assessment for coronary artery bypass grafting (CABG). Because in-hospital mortality following CABG has been studied extensively, risk-adjustment mechanisms are already being used in this area for provider profiling. This study compares eight different risk-adjustment methods as applied to a CABG surgery population of 28 providers. Five of the methods use an external risk-adjustment algorithm developed in an independent population, while the other three rely on an internally developed logistic model. The purposes of this study are to: (i) create a common metric by which to display the results of these various risk-adjustment methodologies with regard to dichotomous outcomes such as in-hospital mortality, and (ii) to compare how these risk-adjustment methods quantify the 'outlier' standing of providers. Section 2 describes the data, the external and internal risk-adjustment algorithms, and eight approaches to provider profiling. Section 3 then demonstrates the results of applying these methods on a data set specifically collected for quality improvement.
๐ SIMILAR VOLUMES
## Sumnlory I n 1985, Miettinen and Nurminen proposed asymptotic likelihood-based methods for the interval estimation of risk differences, risk ratim and risk-odds ratios. In the preaent study, with the use of simulated coverage probabilities in small samples, the actual confidence coefficienta of
## Results of a Prospective Phase 2 Trial With great interest we read the article by Brown et al, who reported the results of a phase 2 study using gemcitabine and cisplatin in patients with advanced endometrial cancer. 1 Although we recognize the reported impressive activity of this regimen, we b